←Back to Expert Scholars
Translational Medicine / 转化医学Cancer Base and Prime Editing
Andrew Anzalone
MD, PhD
🏢Prime Medicine🌐USA
Vice President and Head of Prime Editing Platform
20
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Andrew Anzalone co-invented prime editing in the Liu laboratory and leads platform development at Prime Medicine. His work defined the pegRNA architecture and enables precise search-and-replace genome editing. He is driving translation of prime editing into therapies including oncology applications.
Share:
🧪Research Fields 研究领域
prime editing
pegRNA design
reverse transcriptase fusion
cancer gene correction
search and replace editing
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Andrew Anzalone 的研究动态
Follow Andrew Anzalone's research updates
留下邮箱，当我们发布与 Andrew Anzalone（Prime Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment